AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 35656203 — intervention group
Group type: COMPARATOR
Intervention: Didactic education on firearm injury epidemiology and evidence‐based policies
Number of subjects: 29
Study 33483443 — intervention group
Group type: EXPERIMENTAL
Intervention: YP Face IT (online psychotherapeutic intervention using social interaction skills training and cognitive-behavioural therapy)
Number of subjects: 224
Study 33483443 — intervention group
Group type: COMPARATOR
Intervention: Care as usual (control group)
Number of subjects: 224
Study 33483443 — intervention group
Group type: EXPERIMENTAL
Intervention: YP Face IT
Number of subjects: 224
Study 33483443 — intervention group
Group type: COMPARATOR
Intervention: Care as usual
Number of subjects: 224
Study 33048904 — intervention group
Group type: EXPERIMENTAL
Intervention: Melatonin (10 mg)
Number of subjects: 203
Study 33048904 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 203
Study 33048904 — intervention group
Group type: EXPERIMENTAL
Intervention: Melatonin
Number of subjects: 203
Study 35736001 — intervention group
Group type: EXPERIMENTAL
Intervention: 2-mg trametinib containing 9% DMSO (test formulation)
Number of subjects: 65
Study 35736001 — intervention group
Group type: COMPARATOR
Intervention: 2-mg trametinib containing 11% DMSO (reference formulation)
Number of subjects: 65
Study 35736001 — intervention group
Group type: EXPERIMENTAL
Intervention: Both formulations
Number of subjects: 65
Study 34510203 — intervention group
Group type: EXPERIMENTAL
Intervention: Watermelon juice (WMJ) 500 mL daily for 2 weeks
Number of subjects: 17
Study 34510203 — intervention group
Group type: COMPARATOR
Intervention: Calorie-matched placebo (PLA)
Number of subjects: 17
Study 36239565 — intervention group
Group type: EXPERIMENTAL
Intervention: White noise
Number of subjects: 59
Study 36239565 — intervention group
Group type: EXPERIMENTAL
Intervention: Brahms' lullaby
Number of subjects: 59
Study 36239565 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 59
Study 33326122 — intervention group
Group type: EXPERIMENTAL
Intervention: Virtual reality rehabilitation system (30 minutes) + conventional occupational therapy (30 minutes)
Number of subjects: 80
Study 33326122 — intervention group
Group type: COMPARATOR
Intervention: Conventional occupational therapy (60 minutes)
Number of subjects: 80
Study 35817618 — intervention group
Group type: EXPERIMENTAL
Intervention: Lap‐Tap with liposomal bupivacaine
Number of subjects: 100
Study 35817618 — intervention group
Group type: COMPARATOR
Intervention: US‐Tap with liposomal bupivacaine
Number of subjects: 100
Study 35817618 — intervention group
Group type: COMPARATOR
Intervention: Lap‐Tap and US‐Tap
Number of subjects: 100
Study 33743788 — intervention group
Group type: EXPERIMENTAL
Intervention: AOT-EXO group (action observation treatment-based exoskeleton therapy)
Number of subjects: 132
Study 33743788 — intervention group
Group type: EXPERIMENTAL
Intervention: EXO group (exoskeleton therapy)
Number of subjects: 132
Study 33743788 — intervention group
Group type: COMPARATOR
Intervention: CT group (conventional therapy)
Number of subjects: 132
Study 32598244 — intervention group
Group type: EXPERIMENTAL
Intervention: MenACWY-TT (toddlers)
Number of subjects: 0
Study 32598244 — intervention group
Group type: COMPARATOR
Intervention: MenC-CRM
Number of subjects: 0
Study 32598244 — intervention group
Group type: EXPERIMENTAL
Intervention: MenACWY-TT (children)
Number of subjects: 0
Study 32598244 — intervention group
Group type: COMPARATOR
Intervention: MenACWY-PS
Number of subjects: 0
Study 32598244 — intervention group
Group type: EXPERIMENTAL
Intervention: MenACWY-TT booster
Number of subjects: 0
Study 36251938 — intervention group
Group type: EXPERIMENTAL
Intervention: Controlled oxygenated rewarming (COR)
Number of subjects: 0
Study 36251938 — intervention group
Group type: COMPARATOR
Intervention: Static cold storage (SCS)
Number of subjects: 0
Study 33878017 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-focused Augmented Reality (AR)
Number of subjects: 335
Study 33878017 — intervention group
Group type: EXPERIMENTAL
Intervention: Vicarious Reinforcement
Number of subjects: 335
Study 33878017 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-focused AR and Vicarious Reinforcement
Number of subjects: 335
Study 33878017 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 335
Study 32692370 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinical vignette of a white woman (20 participants, 43%)
Number of subjects: 46
Study 32692370 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinical vignette of an African American woman (20 participants, 43%)
Number of subjects: 46
Study 32692370 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinical vignette of a white man (3 participants, 7%)
Number of subjects: 46
Study 32692370 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinical vignette of an African American man (3 participants, 7%)
Number of subjects: 46
Study 32692370 — intervention group
Group type: EXPERIMENTAL
Intervention: All racial and gender groups
Number of subjects: 46
Study 32692370 — intervention group
Group type: COMPARATOR
Intervention: Surveys
Number of subjects: 46
Study 35314714 — intervention group
Group type: EXPERIMENTAL
Intervention: Risk prediction model for CKD
Number of subjects: 4601
Study 32744859 — intervention group
Group type: EXPERIMENTAL
Intervention: Late luteal phase
Number of subjects: 38
Study 32744859 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher health anxiety (HA) during late luteal phase
Number of subjects: 38
Study 32744859 — intervention group
Group type: EXPERIMENTAL
Intervention: Follicular phase
Number of subjects: 38
Study 35854267 — intervention group
Group type: COMPARATOR
Intervention: Usual care SMS reminder
Number of subjects: 8391
Study 35854267 — intervention group
Group type: COMPARATOR
Intervention: Behavioural plain text SMS reminder
Number of subjects: 8391
Study 35854267 — intervention group
Group type: COMPARATOR
Intervention: Novel video sent as a link within the behavioural plain text SMS reminder
Number of subjects: 8391
Study 33400856 — intervention group
Group type: EXPERIMENTAL
Intervention: Total sleep deprivation (DEP)
Number of subjects: 13
Study 33400856 — intervention group
Group type: COMPARATOR
Intervention: Normal sleep (CON)
Number of subjects: 13
Study 34743575 — intervention group
Group type: EXPERIMENTAL
Intervention: Lifestyle intervention delivered by trained lay volunteers (mentors)
Number of subjects: 104
Study 34481460 — intervention group
Group type: EXPERIMENTAL
Intervention: Nasal High-Flow (NHF) cannula
Number of subjects: 36
Study 34481460 — intervention group
Group type: COMPARATOR
Intervention: Conventional Nasal Cannula (NC2)
Number of subjects: 36
Study 33377700 — intervention group
Group type: EXPERIMENTAL
Intervention: Paclitaxel liposome, 135 mg/m2, administered via intravenous drip for a course of 3 weeks, with 10 mg dexamethasone in 100 ml normal saline on the first day and metoclopramide and panxi tora azole on the second day.
Number of subjects: 40
Study 33377700 — intervention group
Group type: EXPERIMENTAL
Intervention: Paclitaxel liposome treatment for bone metastasis and pain.
Number of subjects: 40
Study 33377700 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall survival rate and median survival time after treatment.
Number of subjects: 40
Study 33377700 — intervention group
Group type: EXPERIMENTAL
Intervention: Safety profile of the treatment.
Number of subjects: 40
Study 35512482 — intervention group
Group type: EXPERIMENTAL
Intervention: Art-based intervention (TICK-B) during venipuncture
Number of subjects: 144
Study 35512482 — intervention group
Group type: COMPARATOR
Intervention: No intervention (control group) during venipuncture
Number of subjects: 144
Study 32969022 — intervention group
Group type: EXPERIMENTAL
Intervention: Cannabidiol (CBD) at a dose of 10 or 20 mg/kg/day for 14 weeks
Number of subjects: 714
Study 32969022 — intervention group
Group type: EXPERIMENTAL
Intervention: Cannabidiol (CBD) in patients receiving clobazam
Number of subjects: 714
Study 32969022 — intervention group
Group type: EXPERIMENTAL
Intervention: Cannabidiol (CBD)
Number of subjects: 714
Study 32969022 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 714
Study 32201143 — intervention group
Group type: EXPERIMENTAL
Intervention: Condensed video ratings by nonexpert raters
Number of subjects: 13
Study 32201143 — intervention group
Group type: COMPARATOR
Intervention: Expert ratings
Number of subjects: 13
Study 32828644 — intervention group
Group type: EXPERIMENTAL
Intervention: Anger management psychoeducation programme (8 weeks)
Number of subjects: 32
Study 32828644 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 32
Study 32145370 — intervention group
Group type: EXPERIMENTAL
Intervention: High-calorie food condition
Number of subjects: 97
Study 32145370 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-calorie food condition
Number of subjects: 97
Study 32145370 — intervention group
Group type: EXPERIMENTAL
Intervention: Neutral/standard response inhibition
Number of subjects: 97
Study 32145370 — intervention group
Group type: EXPERIMENTAL
Intervention: Food stimuli blocks
Number of subjects: 97
Study 32145370 — intervention group
Group type: EXPERIMENTAL
Intervention: Food type
Number of subjects: 97
Study 35102099 — intervention group
Group type: EXPERIMENTAL
Intervention: Multicomponent exercise program (60-minute sessions, 3 days per week for 16 weeks)
Number of subjects: 112
Study 35102099 — intervention group
Group type: EXPERIMENTAL
Intervention: Multicomponent exercise program
Number of subjects: 112
Study 35476887 — intervention group
Group type: EXPERIMENTAL
Intervention: Buprenorphine buccal film (BBF) 300 mcg
Number of subjects: 0
Study 35476887 — intervention group
Group type: EXPERIMENTAL
Intervention: Buprenorphine buccal film (BBF) 600 mcg
Number of subjects: 0
Study 35476887 — intervention group
Group type: EXPERIMENTAL
Intervention: Buprenorphine buccal film (BBF) 900 mcg
Number of subjects: 0
Study 35476887 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate-release (IR) oxycodone 30 mg
Number of subjects: 0
Study 35476887 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate-release (IR) oxycodone 60 mg
Number of subjects: 0
Study 35476887 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 33478837 — intervention group
Group type: EXPERIMENTAL
Intervention: Sutureless valves
Number of subjects: 910
Study 33478837 — intervention group
Group type: COMPARATOR
Intervention: Conventional stented valves
Number of subjects: 910
Study 34358471 — intervention group
Group type: EXPERIMENTAL
Intervention: Liraglutide 3.0 mg daily
Number of subjects: 185
Study 34358471 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 185
Study 32005475 — intervention group
Group type: EXPERIMENTAL
Intervention: Trained evaluators
Number of subjects: 10
Study 32005475 — intervention group
Group type: COMPARATOR
Intervention: Untrained evaluators
Number of subjects: 10
Study 32005475 — intervention group
Group type: EXPERIMENTAL
Intervention: Faculty evaluators
Number of subjects: 10
Study 32005475 — intervention group
Group type: COMPARATOR
Intervention: Residents
Number of subjects: 10
Study 32005475 — intervention group
Group type: EXPERIMENTAL
Intervention: All evaluators on CVM staging for all combined images
Number of subjects: 10
Study 32005475 — intervention group
Group type: EXPERIMENTAL
Intervention: 2D-digital lateral cephalograms with training
Number of subjects: 10
Study 32005475 — intervention group
Group type: EXPERIMENTAL
Intervention: 3D-CBCT images
Number of subjects: 10
Study 36018356 — intervention group
Group type: EXPERIMENTAL
Intervention: Transradial access (TRA)
Number of subjects: 130
Study 36018356 — intervention group
Group type: COMPARATOR
Intervention: Transfemoral access (TFA)
Number of subjects: 130
Study 34032923 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone in addition to routine care
Number of subjects: 48
Study 34032923 — intervention group
Group type: COMPARATOR
Intervention: Routine care only (Control)
Number of subjects: 48
Study 32568368 — intervention group
Group type: EXPERIMENTAL
Intervention: Telephone and Short Message Service Support
Number of subjects: 0
Study 32568368 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study 36216006 — intervention group
Group type: EXPERIMENTAL
Intervention: Allopurinol (up-titrated to 600 mg daily, 300 mg daily for moderate renal impairment)
Number of subjects: 5721
Study 36216006 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 5721
Study 36216006 — intervention group
Group type: EXPERIMENTAL
Intervention: Allopurinol
Number of subjects: 5721
Study 34607114 — intervention group
Group type: EXPERIMENTAL
Intervention: Selenised glucose (SeGlu) at 5 mg/kg
Number of subjects: 360
Study 34607114 — intervention group
Group type: EXPERIMENTAL
Intervention: Selenised glucose (SeGlu) at 10 mg/kg
Number of subjects: 360
Study 34607114 — intervention group
Group type: EXPERIMENTAL
Intervention: Selenised glucose (SeGlu)
Number of subjects: 360
Study 35092498 — intervention group
Group type: EXPERIMENTAL
Intervention: Vonoprazan 10 mg administered every second day for 4 weeks
Number of subjects: 122
Study 35092498 — intervention group
Group type: COMPARATOR
Intervention: Lansoprazole 15 mg administered every second day for 4 weeks
Number of subjects: 122
Study 35092498 — intervention group
Group type: EXPERIMENTAL
Intervention: Vonoprazan 10 mg administered every second day for the second 4 weeks
Number of subjects: 122
Study 35092498 — intervention group
Group type: COMPARATOR
Intervention: Lansoprazole 15 mg administered every second day for the second 4 weeks
Number of subjects: 122
Study 35092498 — intervention group
Group type: EXPERIMENTAL
Intervention: Vonoprazan 10 mg administered every second day for the first 4 weeks
Number of subjects: 122
Study 35092498 — intervention group
Group type: COMPARATOR
Intervention: Lansoprazole 15 mg administered every second day for the first 4 weeks
Number of subjects: 122
Study 33751956 — intervention group
Group type: EXPERIMENTAL
Intervention: COBRA-BPS multicomponent hypertension management programme
Number of subjects: 2645
Study 33818343 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy
Number of subjects: 259
Study 33818343 — intervention group
Group type: COMPARATOR
Intervention: Control (waitlist, discussion group, or supportive therapy)
Number of subjects: 259
Study 33818343 — intervention group
Group type: COMPARATOR
Intervention: PSWQ‐A
Number of subjects: 259
Study 32853005 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinician-Administered PTSD Scale (CAPS) with IRT estimation incorporating symptom weights and group-specific DIF
Number of subjects: 506
Study 32853005 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinician-Administered PTSD Scale (CAPS) with symptom counts
Number of subjects: 506
Study 36130667 — intervention group
Group type: EXPERIMENTAL
Intervention: Norgestrel 0.075 mg progestogen-only pill taken 6 hours late
Number of subjects: 46
Study 36130667 — intervention group
Group type: EXPERIMENTAL
Intervention: Norgestrel 0.075 mg progestogen-only pill missed completely
Number of subjects: 46
Study 36130667 — intervention group
Group type: EXPERIMENTAL
Intervention: Norgestrel 0.075 mg progestogen-only pill (both interventions)
Number of subjects: 46
Study 36130667 — intervention group
Group type: EXPERIMENTAL
Intervention: Theoretical contraceptive protection
Number of subjects: 46
Study 32401625 — intervention group
Group type: EXPERIMENTAL
Intervention: Education based on the BASNEF model including personal education and a manual CD of physical activity
Number of subjects: 40
Study 32401625 — intervention group
Group type: COMPARATOR
Intervention: Control group (details not specified)
Number of subjects: 40
Study 35676163 — intervention group
Group type: EXPERIMENTAL
Intervention: Hybrid screw fixation (one fully threaded calcar screw & two partially threaded superior screws)
Number of subjects: 20
Study 35676163 — intervention group
Group type: COMPARATOR
Intervention: Partially threaded screws (all screws partially threaded)
Number of subjects: 20
Study 34948661 — intervention group
Group type: EXPERIMENTAL
Intervention: Gender equality curriculum including script relationship training for two months
Number of subjects: 54
Study 34948661 — intervention group
Group type: COMPARATOR
Intervention: Regular curriculum
Number of subjects: 54
Study 32499257 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower Socioeconomic Position (SEP)
Number of subjects: 1412
Study 35091325 — intervention group
Group type: EXPERIMENTAL
Intervention: Abatacept treatment for 48 weeks
Number of subjects: 40
Study 33105154 — intervention group
Group type: EXPERIMENTAL
Intervention: Mirror visual feedback + electromyographic biofeedback
Number of subjects: 46
Study 33105154 — intervention group
Group type: EXPERIMENTAL
Intervention: Mirror visual feedback
Number of subjects: 46
Study 33105154 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 46
Study 32370540 — intervention group
Group type: EXPERIMENTAL
Intervention: High ammonia (HA) at 75 ± 5 ppm
Number of subjects: 176
Study 32370540 — intervention group
Group type: COMPARATOR
Intervention: Low ammonia (LA) at 5 ± 5 ppm
Number of subjects: 176
Study 34665672 — intervention group
Group type: EXPERIMENTAL
Intervention: 3-month vaginal ring
Number of subjects: 49
Study 34665672 — intervention group
Group type: COMPARATOR
Intervention: 1-month vaginal ring
Number of subjects: 49
Study 33757497 — intervention group
Group type: EXPERIMENTAL
Intervention: Genetic predisposition to type 2 diabetes
Number of subjects: 133010
Study 33757497 — intervention group
Group type: EXPERIMENTAL
Intervention: Fasting glucose
Number of subjects: 133010
Study 33757497 — intervention group
Group type: EXPERIMENTAL
Intervention: Glycemic traits
Number of subjects: 133010
Study 32028895 — intervention group
Group type: EXPERIMENTAL
Intervention: Perceived link between HIV and TB
Number of subjects: 882
Study 32028895 — intervention group
Group type: EXPERIMENTAL
Intervention: Link between HIV and TB
Number of subjects: 882
Study 32028895 — intervention group
Group type: EXPERIMENTAL
Intervention: Stigmatization of both diseases by colleagues
Number of subjects: 882
Study 34259202 — intervention group
Group type: EXPERIMENTAL
Intervention: Apalutamide
Number of subjects: 221
Study 34259202 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 221
Study 35781341 — intervention group
Group type: EXPERIMENTAL
Intervention: Ceftolozane/tazobactam
Number of subjects: 61
Study 35781341 — intervention group
Group type: COMPARATOR
Intervention: Meropenem
Number of subjects: 61
Study 32619868 — intervention group
Group type: EXPERIMENTAL
Intervention: Extended-release naltrexone (XR-NTX)
Number of subjects: 73
Study 32619868 — intervention group
Group type: COMPARATOR
Intervention: Sublingual buprenorphine-naloxone (BUP-NX)
Number of subjects: 73
Study 35037328 — intervention group
Group type: EXPERIMENTAL
Intervention: Nomogram (developed using logistic and Lasso regression)
Number of subjects: 2113
Study 35037328 — intervention group
Group type: EXPERIMENTAL
Intervention: Nomogram
Number of subjects: 2113
Study 35037328 — intervention group
Group type: COMPARATOR
Intervention: STOP-Bang
Number of subjects: 2113
Study 33853794 — intervention group
Group type: COMPARATOR
Intervention: FOBT screening every other year
Number of subjects: 251528
Study 33853794 — intervention group
Group type: COMPARATOR
Intervention: Once-only sigmoidoscopy screening
Number of subjects: 251528
Study 32817078 — intervention group
Group type: EXPERIMENTAL
Intervention: LenMT at 25 mg/day
Number of subjects: 94
Study 32817078 — intervention group
Group type: COMPARATOR
Intervention: LenMT at 5 mg/day
Number of subjects: 94
Study 34449265 — intervention group
Group type: EXPERIMENTAL
Intervention: Active videogames (AVG)
Number of subjects: 0
Study 34449265 — intervention group
Group type: EXPERIMENTAL
Intervention: Running
Number of subjects: 0
Study 35729041 — intervention group
Group type: EXPERIMENTAL
Intervention: Polypropylene (Prolene 6/0; Ethicon Inc.)
Number of subjects: 31
Study 35729041 — intervention group
Group type: COMPARATOR
Intervention: Polyglactin (Irradiated polyglactin 911, Vicryl Rapid™ 6/0; Ethicon Inc.)
Number of subjects: 31
Study 34248660 — intervention group
Group type: EXPERIMENTAL
Intervention: Flywheel exercise at 0.025 kg m2
Number of subjects: 30
Study 34248660 — intervention group
Group type: EXPERIMENTAL
Intervention: Flywheel exercise at 0.05 kg m2
Number of subjects: 30
Study 34248660 — intervention group
Group type: EXPERIMENTAL
Intervention: Flywheel exercise at 0.075 kg m2
Number of subjects: 30
Study 34248660 — intervention group
Group type: EXPERIMENTAL
Intervention: Flywheel exercise at all loads
Number of subjects: 30
Study 34248660 — intervention group
Group type: EXPERIMENTAL
Intervention: Flywheel exercise at high load
Number of subjects: 30
Study 34619239 — intervention group
Group type: EXPERIMENTAL
Intervention: Obese patients
Number of subjects: 1236
Study 34619239 — intervention group
Group type: EXPERIMENTAL
Intervention: Underweight patients
Number of subjects: 1236
Study 34619239 — intervention group
Group type: EXPERIMENTAL
Intervention: Overweight patients
Number of subjects: 1236
Study 34619239 — intervention group
Group type: EXPERIMENTAL
Intervention: Normalweight men
Number of subjects: 1236
Study 34619239 — intervention group
Group type: EXPERIMENTAL
Intervention: Obese patients receiving oxaliplatin added to standard CRT
Number of subjects: 1236
Study 32640130 — intervention group
Group type: COMPARATOR
Intervention: Tofersen (20 mg)
Number of subjects: 50
Study 32640130 — intervention group
Group type: COMPARATOR
Intervention: Tofersen (40 mg)
Number of subjects: 50
Study 32640130 — intervention group
Group type: COMPARATOR
Intervention: Tofersen (60 mg)
Number of subjects: 50
Study 32640130 — intervention group
Group type: COMPARATOR
Intervention: Tofersen (100 mg)
Number of subjects: 50
Study 32640130 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study 35721034 — intervention group
Group type: EXPERIMENTAL
Intervention: 2% grape seed extract mouthwash (GSE)
Number of subjects: 45
Study 35721034 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.2% chlorhexidine mouthwash (CHX)
Number of subjects: 45
Study 35721034 — intervention group
Group type: COMPARATOR
Intervention: Distilled water (control)
Number of subjects: 45
Study 35145761 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate Full Weight-Bearing (FWB)
Number of subjects: 32
Study 35145761 — intervention group
Group type: COMPARATOR
Intervention: Partial Weight-Bearing (PWB)
Number of subjects: 32
Study 35145761 — intervention group
Group type: EXPERIMENTAL
Intervention: Both FWB and PWB
Number of subjects: 32
Study 34279428 — intervention group
Group type: EXPERIMENTAL
Intervention: Natural and Conventional Cosmetics
Number of subjects: 268
Study 32673215 — intervention group
Group type: EXPERIMENTAL
Intervention: Sun Safe Partners Online
Number of subjects: 75
Study 32673215 — intervention group
Group type: COMPARATOR
Intervention: Generic Online Sun Safety Information
Number of subjects: 75